Abstract
Purpose:
To determine which optimized image quality metric (IQM) refractions provide the best predicted visual acuity (VA).
Methods:
Autorefraction (AR), habitual refraction (spectacles, n = 23; unaided, n = 7), and dilated wavefront error (WFE) were obtained from 30 subjects with Down syndrome (DS; mean age, 30 years; range, 18–50). For each eye, the resultant metric value for 16 IQMs was calculated after >25000 sphero-cylindrical combinations of refraction were added to the measured WFE to generate residual WFE. The single refraction corresponding to each of the 16 optimized IQMs per eye was selected and used to generate acuity charts. Charts also were created for AR, habitual refraction, and a theoretical zeroing of all lower-order aberrations, and grouped into 10 sets with a clear chart in each set. Dilated controls (five observers per set) read each chart until five letters were missed on a high contrast monitor through a unit magnification telescope with a 3 mm pupil aperture. Average letters lost for the five observers for each chart was used to rank the IQMs for each DS eye.
Results:
Average acuity for the best performing refraction for all DS eyes was within five letters (0.11 ± 0.05 logMAR) of the clear chart acuity. Optimized IQM refractions had ∼3.5 lines mean improvement from the habitual refraction (0.37 ± 0.22 logMAR, P < 0.001). Three metrics (Visual Strehl Ratio [VSX], VSX computed in frequency domain [VSMTF], and standard deviation of intensity values [STD]) identified refractions that were ranked first, or within 0.09 logMAR of first, in >98% of the eyes.
Conclusions:
Optimized IQM refraction is predicted to improve VA in DS eyes based on control observers reading simulated charts.
Translational Relevance:
Refractions identified through optimization of IQM may bypass some of the challenges of current refraction techniques for patients with DS. The optimized refractions are predicted to provide better VA compared to their habitual correction.
Thirty-four individuals with DS were recruited from local DS organizations (e.g., Friends with Down syndrome, local Special Olympics chapters, and the Baylor College of Medicine Transition Medicine Clinic). Subjects wearing spectacles had their spectacle lens power measured with auto-lensometry (n = 23). Nondilated distance autorefraction (Grand Seiko WAM-5500; RyuSyo Industrial Co., Ltd. Hiroshima, Japan) then was used to measure the uncorrected refractive error of all subjects. No subjects with DS presented with contact lens corrections.
Aided presenting VA (or unaided if subjects did not wear correction) was measured three times in each eye (approximately 10 to 15 minutes total testing time) using a logMAR acuity method with charts presented on a gamma-corrected LCD monitor with the room lights off. The monitor had a background luminance of 415 cd/m2 and, thus, the white background of the acuity chart provided overall dim room illumination. Each subject's pupil diameter was monitored with the PowerRef 3 (Plusoptix, Nuremberg, Germany), a dynamic, infrared photorefractor, as they performed acuity testing. To avoid false pupil size measures from spectacle lens minification/magnification, subjects' presenting spectacle powers were placed in a trial frame over the tested eye while the nontested eye was left uncorrected and visually occluded with a Wratten 89B filter (Kodak, Rochester, NY; passes infrared light, but blocks visible light). The eye with the Wratten filter was the eye monitored for pupil size during acuity testing. We tested 23 subjects with DS in this fashion with their correction in the trial frame. The other subjects with DS did not present with any correction and, thus, were tested unaided with only the Wratten filter over the fellow eye. The average pupil size during acuity testing was calculated for each subject from these data.
Subjects then were dilated with one drop of 1% tropicamide, followed by one drop of 2.5% phenylephrine. Additional drops were instilled if pupil size had not become noticeably larger after 15 minutes. At 30 minutes after dilation, wavefront aberrometry was recorded in each eye with the Discovery Wavefront Sensor (Innovative Visual Systems, Elmhurst, IL) and reported as 2nd to 10th order Zernike coefficients. Repeated measurements were taken until five good quality measurements were obtained in each eye as judged by the displayed spot pattern (large pupil, no obstruction by lashes, and minimal reflection/scatter). Two subjects were excluded due to an inability to obtain pupil size data during VA testing. One subject was excluded due to an inability to obtain wavefront measures related to poor fixation ability of the subject. One was excluded from the study due to previous cataract surgery in the left eye and visually significant cataract in the right eye.
In addition to the residual WFE calculations for the 16 IQM optimized refractions, residual WFE also was calculated for corrections corresponding to the measured autorefraction and the habitual spectacle corrections worn. For subjects without habitual spectacles, residual wavefront with no refraction was generated in lieu of the habitual spectacle correction condition. Lastly, a theoretical condition was generated for which lower order terms were set to zero, termed LOAZ, and the remaining higher order wavefront included in the simulation. In total, the residual WFE for 19 conditions per eye were calculated for each subject.
Acuity of Best-Performing Refractive Condition Versus Habitual Refraction Condition